11,202 Results
CHMP recommends Baqsimi, the first treatment for severe hypoglycaemia administered without an injection to patients with diabetes aged four years and older.- Eli Lilly
Added 4 hours ago
EMA’s human medicines committee (CHMP) has recommended granting a marketing authorisation in the European Union for Baqsimi (glucagon), from Eli...
Evenity receives positive CHMP opinion for treatment of severe osteoporosis in postmenopausal women at high risk of fracture. Amgen + UCB
Added 1 day ago
Amgen and UCB announced that following a re-examination procedure, the Committee for Medicinal Products for Human Use (CHMP) of the...
Phase III VOYAGE 1 study of Tremfya shows efficacy in plaque psoriasis.- Janssen
Added 1 day ago
The Janssen Pharmaceutical Companies of Johnson & Johnson announced new long-term data from the open-label period of the Phase III...
CHMP recommends approval of Kalydeco in cystic fibrosis CFTR gene mutation.- Vertex Pharma
Added 1 day ago
Vertex Pharmaceuticals (Europe) Limited announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted...
Submission to EMA for Nuzyra in ABSSSI and CABP withdrawn.- Paratek Pharma
Added 1 day ago
Paratek Pharmaceuticals announced that the company has withdrawn its submission to the European Medicines Agency (EMA) of the Marketing Authorization...
CHMP recommends approval of Darzalex + lenalidomide and dexamethasone in multiple myeloma.- Genmab
Added 1 day ago
Genmab announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued...
CHMP recommends approval of Keytruda in head and neck squamous cell carcinoma.- Merck Inc.
Added 1 day ago
Merck announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a...
Herzuma and Truxima biosimilars to be distributed in Australia by Celltrion and to hospitals by Juno Pharmaceuticals.
Added 1 day ago
Celltrion Healthcare (Celltrion) has entered into a partnership with Juno Pharmaceuticals (Juno) ( not to be confused with Juno Therapeutics)...
CHMP does not recommend approval of quizartinib for use in acute myeloid leukemia.- Daiichi Sankyo
Added 1 day ago
Daiichi Sankyo announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted...
CHMP recommends approval of Tavalisse in chronic immune thrombocytopenia.- Rigel Pharma
Added 1 day ago
Rigel Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), has...